Stockscreener 앱 받기
14.70
0.96%
0.14
전일 마감가:
$14.56
열려 있는:
$14.7
하루 거래량:
9,077
Relative Volume:
0.48
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.64%
1개월 성능:
-8.13%
6개월 성능:
-19.28%
1년 성능:
-12.08%
1일 변동 폭
$14.70
$14.90
1주일 범위
$14.54
$15.43
52주 변동 폭
$14.38
$21.88
Kraneshares Msci All China Health Care Index Etf Stock (KURE) Company Profile
명칭
Kraneshares Msci All China Health Care Index Etf
전화
-
주소
-
Compare KURE vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KURE
Kraneshares Msci All China Health Care Index Etf
|
14.70 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
369.99 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
746.74 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
750.11 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
296.51 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
740.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Kraneshares Msci All China Health Care Index Etf 주식(KURE)의 최신 뉴스
Legend Biotech Corp (LEGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Healthcare ETF: Outbound Biotech Licensing As Potential New Growth Driver In China - KraneShares
KURE ETF Holdings List — BIVA:KURE - TradingView
KURE ETF Analysis: Dividends, Returns BIVA:KURE - TradingView
KURE Stock Fund Price and Chart — BIVA:KURE - TradingView
Why Is KraneShares MSCI All China Health Care Index ETF (KURE) Stock Up Today? - Meyka
ETFs Investing in Sino Biopharmaceutical Limited Stocks - TradingView
How Kraneshares Msci All China Health Care Index Etf (KURE) Affects Rotational Strategy Timing - Stock Traders Daily
(KURE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
ETFs Investing in BeOne Medicines Ltd. Stocks - TradingView
Responsive Playbooks and the KURE Inflection - Stock Traders Daily
ETFs Investing in Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A Stocks - TradingView
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
ETFs Investing in XtalPi Holdings Limited Stocks - TradingView
Understanding the Setup: (KURE) and Scalable Risk - Stock Traders Daily
The Technical Signals Behind (KURE) That Institutions Follow - Stock Traders Daily
Accessing Chinese Health Care Companies - stockinvestor.com
Precision Trading with Kraneshares Msci All China Health Care Index Etf (KURE) Risk Zones - Stock Traders Daily
Stock List: Research Stocks from Around the World - GuruFocus
KURE, EEMA, CHIH: Chinese Healthcare ETFs Have the Potential for Big Gains - TipRanks
Technical Reactions to KURE Trends in Macro Strategies - Stock Traders Daily
Trading the Move, Not the Narrative: (KURE) Edition - news.stocktradersdaily.com
China ETF News: Retail Sales Beat Estimates - Seeking Alpha
KURE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
(KURE) Volatility Zones as Tactical Triggers - Stock Traders Daily
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs - TipRanks
Price-Driven Insight from (KURE) for Rule-Based Strategy - Stock Traders Daily
KURE, EEMA, CHIH: Get Exposure to Chinese Technology Through Healthcare ETFs - TipRanks
(KURE) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
China ETFs: A Comprehensive Guide On How To Invest In China - KraneShares
(KURE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
(KURE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Beyond U.S. Tech Stocks — Top Asia AI Opportunities for 2026 - TheStreet Pro
KraneShares TrustKraneShares MSCI All China Health Care Index ETF announces Annual dividend, payable on December 23, 2025 - MarketScreener
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
5 Biggest Pharmaceutical ETFs in 2025 - Nasdaq
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermedia - Benzinga
KURE - KraneShares
KCAI - KraneShares
KEMX - KraneShares
KBA - KraneShares
KraneShares MSCI All China Health Care Index ETF Trade Ideas — AMEX:KURE - TradingView
Should EM Investors Trim or Retain Their China Exposure?VettaFiCommentaries - Advisor Perspectives
ETFs Investing in Innovent Biologics, Inc. Stocks - TradingView
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Capitalize on China Healthcare Fundraising With KURE - ETF Trends
ETFs Investing in WuXi AppTec Co., Ltd. Class A Stocks - TradingView
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
China Update: New IPOs, Healthcare Momentum, New Hydroelectric Dam - Seeking Alpha
Kraneshares Msci All China Health Care Index Etf (KURE) 재무 분석
Kraneshares Msci All China Health Care Index Etf (KURE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.19%
자본화:
|
볼륨(24시간):